Sector valuations Vertex Pharmaceuticals Incorporated

Stocks

Real-time Estimate Cboe BZX 22:03:12 25/09/2026 +03			5-day change	1st Jan Change
525.56 ^USD	+0.61%		+3.33%	+15.86%

09-23	TD Cowen Adjusts PT on Vertex Pharmaceuticals to $550 From $525, Maintains Buy Rating	MT
09-23	Jefferies Adjusts Price Target on Vertex Pharmaceuticals to $640 From $633, Maintains Buy Rating	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	Price to Book (Y)	PEG (Y)	EV / Sales (Y)	EV / EBITDA (Y)	EV / EBIT (Y)	Dividend Yield (Y)	Capi.($)
VERTEX PHARMACEUTICALS INCORPORATED	53.69x	8.48x	-1.47x	9.67x	33.16x	26.69x	-.--%	132B
ELI LILLY AND COMPANY	33.6x	21.36x	0.63x	12.18x	24.75x	26.19x	0.59%	1,053B
JOHNSON & JOHNSON	30.11x	-	-1.63x	6.7x	18.74x	21.06x	1.98%	652B
ABBVIE INC.	33.53x	-482.8x	0.14x	7.84x	16.21x	16.89x	2.59%	468B
ROCHE HOLDING AG	19.76x	7.23x	1.35x	4.82x	11.93x	13.23x	2.75%	351B
NOVARTIS AG	20.25x	5.76x	-11.68x	5.27x	13.08x	13.95x	3.03%	273B
ASTRAZENECA PLC	20.9x	4.71x	1.05x	4.34x	12.34x	12.99x	2.04%	254B
AMGEN INC.	25.65x	19.4x	2.28x	6.7x	11.94x	15.39x	2.48%	220B
GILEAD SCIENCES, INC.	-45.27x	11.15x	0.3x	6.59x	25.75x	62.46x	2.2%	186B
NOVO NORDISK A/S	11.33x	4.78x	-3.77x	4.13x	8.58x	10.04x	4.44%	170B
PFIZER INC.	17.92x	1.85x	1.08x	3.36x	8.62x	9.8x	6.06%	162B
BRISTOL-MYERS SQUIBB COMPANY	10.95x	5.16x	0.18x	3.1x	8.06x	8.68x	4.11%	126B
GSK PLC	14.57x	4.64x	-1.68x	2.84x	8.41x	9.35x	3.71%	99.42B
SANOFI	11.48x	1.17x	-6.08x	2.05x	6.64x	7.35x	5.9%	98.2B
CHUGAI PHARMACEUTICAL CO., LTD.	21.62x	4.87x	1.3x	7.23x	13.71x	14.39x	2.05%	68.82B
TAKEDA PHARMACEUTICAL COMPANY LIMITED	46.6x	1.26x	13.22x	2.83x	10.36x	28.3x	3.47%	59.11B
BAYER AG	22.34x	1.72x	-0.14x	1.71x	8.08x	13.86x	0.32%	55.15B
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	32.22x	4.35x	1.79x	7.51x	25.45x	28.47x	0.54%	43.99B
HALEON PLC	17.93x	1.8x	4.49x	3.27x	12.2x	13.6x	2.34%	40.16B
Average	21.01x	-20.73x	0.07x	5.38x	14.63x	18.56x	2.66%	237.48B
Weighted average by Cap.	24.21x	-48.66x	-0.55x	7.19x	17.19x	20.12x	2.23%